By Charina Clarisse E. Echaluce
The University of the Philippines-Philippine General Hospital will provide an independent review and assessment on the probable cause of deaths among children who were inoculated with the controversial dengue vaccine Dengvaxia.
“We are being transparent to erase doubts of some sectors and the public that the Department of Health is allegedly concealing material information resulting from Dengvaxia vaccination. The UP-PGH, as the national university hospital, is the most credible third party institution to conduct this review for the DoH as it has the clinical and research expertise as well as mandate to provide assistance on matters of important health concern,” Health Secretary Francisco T. Duque III said.
“UP-PGH will be providing an independent review and assessment on the probable cause of deaths submitted by the DoH through an expert group of pediatric infectious disease experts together with some forensic pathologists and other specialists with no financial and intellectual ties with Sanofi Pasteur,” Duque added.
